BusinessSera Prognostics to Present at the 11th Annual Canaccord Genuity Medical Technologies and Diagnostics ForumBy Nasdaq OMXNov 6, 2017, 3:00 PM UTC
BusinessSera Prognostics to Present at the Baird 2017 Global Healthcare ConferenceBy Nasdaq OMXSep 5, 2017, 2:49 PM UTC
BusinessSera Prognostics Receives Accreditation from College of American PathologistsBy Nasdaq OMXJun 29, 2017, 1:00 PM UTC
BusinessSera Prognostics is Named a 2017 Silver Edison Award WinnerBy Nasdaq OMXApr 21, 2017, 11:00 AM UTC
BusinessLandmark Study Published in American Journal of Obstetrics & Gynecology Validates New Blood Test as Objective, Predictive Tool for Preterm Birth RiskBy Nasdaq OMXMar 10, 2016, 12:00 PM UTC
BusinessPositive Clinical Validation Data for PreTRM® Test Presented at the Society for Maternal-Fetal Medicine’s 36th Annual Pregnancy MeetingBy Nasdaq OMXFeb 4, 2016, 8:15 PM UTC
